Patients must have fully recovered from any adverse effects of major surgery (to =< grade ) at least  days prior to registration
Patient must have recovered from the surgery
Recovered from any previous surgery and no history of major surgery within the last  days prior to start of study drug
Subject had major surgery within  weeks prior to randomization (kyphoplasty is not considered major surgery); subjects should have been fully recovered from any surgical related toxicities.
? weeks since any major surgery and fully recovered.
History or major surgery within  weeks before the first dose of study treatment, or not recovered from prior surgery
Has not fully recovered from any effects of major surgery without significant detectable infection.
Prior major surgery within  weeks or prior major surgery from which the patient has not sufficiently recovered yet
PHASE II EXCLUSION CRITERIA: Prior major surgery within  weeks or prior major surgery from which the patient has not sufficiently recovered yet
Reasonably recovered from preceding major surgery as judged by the investigator or no major surgery within  weeks prior to the start of Day  treatment
Not recovered from AEs and/or complications from major surgery prior to first dose
Major thoracic or abdominal surgery from which the patient has not sufficiently recovered yet
Fully recovered from any effects of major surgery, and be free of significant infection
Reasonably recovered from preceding major surgery as judged by the investigator or no major surgery within  weeks prior to the start of Day  treatment
Patients who have had major surgery must be fully recovered and >=  weeks post-operative prior to enrolling on study
Patients who have undergone major surgery within the  weeks prior to starting study treatment or who have not fully recovered from previous surgery
Major surgery must have been completed ?  weeks prior to starting treatment day ; patient must be sufficiently recovered and stable from surgery prior to treatment day 
Major surgery within  weeks prior to day  of the study or who have not recovered from prior surgery
Patients who have had major surgery must be fully recovered and require a recovery period of >=  weeks prior to enrolling on study
Reasonably recovered from preceding major surgery as judged by the Investigator or no major surgery within  weeks prior to the start of Day  treatment
Major surgery within  weeks prior to study day  (subjects must have completely recovered from any previous surgery prior to study day ); biopsy, diagnostic tonsillectomy, airway tumor debulking or excisional lymph node biopsy do not constitute major surgery
Major thoracic or abdominal surgery from which the patient has not sufficiently recovered yet
Adequate recovery from all recent surgery is required. At least -days must have elapsed from the time of any major surgery, including craniotomy/tumor resection. Patients must have recovered from all surgery-related toxicities to Grade  or less.
Patients may not have had any prior tumor treatment except for surgery, and must have adequately recovered from surgery
Patients who have undergone a major surgery, including surgery for a new artificial implant and/or device, within  weeks prior to the initiation of ADXS- treatment; NOTE: All toxicities and/or complications must have recovered to baseline or grade\r\n prior to the initiation of ADXS- study therapy; sponsor must be consulted prior to enrolling subjects on the study who recently had a major surgery or have new artificial implant, and/or devices
Patients may have received prior surgery provided that at least  days have elapsed since major surgery (thoracic or other major surgeries) and the patient has recovered from all associated toxicities. Patients must have disease outside of the previous surgical resection area or a new lesion must be present.
Patients must have recovered from the surgery
Major surgery <= weeks before the first dose of study treatment. Subjects must have also fully recovered from any surgery (major or minor) and/or its complications before initiating study treatment.
Major surgery (eg., requiring general anesthesia) within  weeks before screening, or will not have fully recovered from surgery, or has surgery planned during the time the subject is expected to participate in the study
At least  weeks have elapsed since the completion of major surgery, and the patient has fully recovered from this surgery and any post-surgical complications
Patient who has undergone major surgery =<  weeks prior to starting study treatment or who has not recovered from side effects of such procedure; note: core needle biopsy, diagnostic tonsillectomy or excisional lymph node biopsy do not constitute major surgery
Major surgery within  weeks prior to day  of the study or who have not recovered from prior surgery
Patients must be at least  weeks ( days) from major surgery and fully recovered from all acute effects of prior surgical intervention
Major thoracic or abdominal surgery from which the patient has not yet recovered.
Subjects must have recovered from surgery before study registration
Patients may have received prior surgery (e.g., pleurectomy, pleurodeisis) provided at least  days have elapsed since surgery (thoracic or other major surgeries) and patients have recovered from all associated toxicities at the time of registration; there must be no anticipated need for major surgical procedures during protocol treatment
Patients may have received prior surgery; for all major surgeries, at least  days must have elapsed since completion and patient must have recovered from all major side effects of surgery per investigators assessment
Major surgery for any reason, except diagnostic biopsy, within  weeks of enrolment and/or if the subject has not fully recovered from the surgery within  weeks of enrolment
PRIOR/CONCURRENT THERAPY CRITERIA: Patients must not have had a major surgery within  days prior to registration; patients must have recovered from any adverse effects of prior surgery to the satisfaction of the treating physician; biopsies and central IV access placement are not considered major surgery
Major surgery for any reason, except diagnostic biopsy, within  weeks and/or if the subject has not fully recovered from the surgery within  weeks
Are at least  weeks from major surgery and recovered.
Plan for any major surgery during treatment period.
Major surgery within  weeks prior to Day  of study or who have not recovered from prior surgery
Patients must be at least  weeks from major surgery and must be fully recovered
Patients may have received prior surgery (e.g., pleurectomy) provided that at least  days have elapsed since surgery (thoracic or other major surgeries) and patients have recovered (i.e., =< grade  or at baseline) from all associated toxicities at the time of registration; there must be no anticipated need for major surgical procedures during protocol treatment
Major thoracic or abdominal surgery from which the patient has not yet recovered.
PART B: Patients who have had major surgery within  days prior to entering the study or those who have not recovered from adverse events > grade  relating to the surgery
Fully recovered from any prior surgery and/or radiation and none within  weeks of initiating treatment
Patients who have not recovered from prior surgery
Major surgery within  weeks prior to day  of study treatment from which the patient has not completely recovered
Patients having undergone major surgery less than  weeks prior to enrollment or have not fully recovered from prior surgery
Major surgery within  weeks prior to day  of the study or who have not recovered from prior surgery
Patient has undergone a major surgery, including surgery for a new artificial implant and/or device, within  weeks prior to the initiation of ADXS- treatment; NOTE: all toxicities and/or complications must have recovered to baseline or grade  prior to the initiation of ADXS- study therapy; sponsor must be consulted prior to enrolling patients on the study who recently had a major surgery or have new artificial implant, and/or devices
Major surgery within three months prior to Day  of study or who have not recovered adequately from prior surgery.
Patients who have had major surgery must be fully recovered and >=  weeks post-operative prior to enrolling on study
Major surgery within  weeks prior to day  of the study or who have not recovered from prior surgery
Major surgery within  weeks prior to Baseline. The subject must have recovered from surgery and be without current complications of infection or dehiscence.
At least  weeks have elapsed since the completion of major surgery, and the patient has fully recovered from this surgery and any post-surgical complications.
Patients must be at least  weeks from major surgery and have fully recovered from any effects of surgery, and be free of significant detectable infection prior to registration
Plan for any major surgery during treatment period.
Prior major surgery from which the subject has not yet recovered to baseline;
Be reasonably recovered from preceding major surgery as judged by the investigator or no major surgery within  weeks prior to the start of day  treatment
Patients must have fully recovered from any effects of major surgery, and be free of significant detectable infection
Fully recovered from any prior surgery and no major surgery within  weeks of initiating treatment, except for gamma knife which can take place within  weeks. Surgery for placement of vascular access devices is acceptable.
Patients must be at least  weeks from major surgery and have fully recovered from any effects of surgery, and be free of significant detectable infection
If a patient has had major surgery, the patient must be longer than four weeks post surgery and must have recovered from all toxicity prior to beginning protocol study
Major surgery/surgical therapy for any cause within  month prior to pasireotide administration; patients should have recovered and have a good clinical condition before entering the study
Have reasonably recovered from preceding major surgery as judged by the investigator or have had no major surgery within  weeks prior to Day  treatment.
Patient is planning major surgery within the next  months
>=  weeks since last major surgery and fully recovered
Patients must have recovered from prior surgery
Recovered from major surgery within the last  months
The patient must be recovered from a prior major surgery; the major surgery must be performed at least  weeks prior to consent date
Participants with acute intercurrent illness or those who had major surgery within the preceding  weeks unless they have fully recovered
Participants with acute intercurrent illness or those who had surgery within the preceding  weeks unless they have fully recovered
Patients may have received prior radiation therapy or major surgery; however, at least  days prior to treatment start must have elapsed since completion of radiation therapy or major surgery and patient must have recovered from all side effects at the time of randomization
recovered from any prior surgery
